Jiuzhitang Co Ltd (000989) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiuzhitang Co Ltd (000989) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.91 Million ≈ $14.77 Million USD) by net assets (CN¥3.86 Billion ≈ $564.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiuzhitang Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Jiuzhitang Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Jiuzhitang Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiuzhitang Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiuzhitang Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Preformed Line Products Company
NASDAQ:PLPC
|
0.041x |
|
Gracell Biotechnologies Inc.
NASDAQ:GRCL
|
-0.039x |
|
Luye Pharma Group Ltd
F:LUP
|
0.019x |
|
Xiamen East Asia Machinery Industrial Co. Ltd.
SHE:301028
|
N/A |
|
Mega Fortune Company Limited Ordinary Shares
NASDAQ:MGRT
|
N/A |
|
TWO HARBORS INV. DL-0001
F:2H2
|
0.066x |
|
Sdiptech AB (publ)
ST:SDIP-B
|
0.029x |
|
CTS International Logistics Corp Ltd
SHG:603128
|
0.000x |
Annual Cash Flow Conversion Efficiency for Jiuzhitang Co Ltd (2000–2024)
The table below shows the annual cash flow conversion efficiency of Jiuzhitang Co Ltd from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Jiuzhitang Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.95 Billion ≈ $577.71 Million |
CN¥198.96 Million ≈ $29.11 Million |
0.050x | +63.86% |
| 2023-12-31 | CN¥3.95 Billion ≈ $577.62 Million |
CN¥121.40 Million ≈ $17.76 Million |
0.031x | -75.46% |
| 2022-12-31 | CN¥3.98 Billion ≈ $582.71 Million |
CN¥499.13 Million ≈ $73.04 Million |
0.125x | +36.00% |
| 2021-12-31 | CN¥3.97 Billion ≈ $580.97 Million |
CN¥365.91 Million ≈ $53.54 Million |
0.092x | -40.65% |
| 2020-12-31 | CN¥3.93 Billion ≈ $574.41 Million |
CN¥609.56 Million ≈ $89.20 Million |
0.155x | -27.19% |
| 2019-12-31 | CN¥3.99 Billion ≈ $584.12 Million |
CN¥851.29 Million ≈ $124.57 Million |
0.213x | +115.87% |
| 2018-12-31 | CN¥4.31 Billion ≈ $630.78 Million |
CN¥425.86 Million ≈ $62.32 Million |
0.099x | +192.68% |
| 2017-12-31 | CN¥4.50 Billion ≈ $658.92 Million |
CN¥152.00 Million ≈ $22.24 Million |
0.034x | -77.19% |
| 2016-12-31 | CN¥4.14 Billion ≈ $605.43 Million |
CN¥612.38 Million ≈ $89.61 Million |
0.148x | +65.37% |
| 2015-12-31 | CN¥3.79 Billion ≈ $554.28 Million |
CN¥339.03 Million ≈ $49.61 Million |
0.090x | +21.45% |
| 2014-12-31 | CN¥1.61 Billion ≈ $235.48 Million |
CN¥118.59 Million ≈ $17.35 Million |
0.074x | +299.46% |
| 2013-12-31 | CN¥1.54 Billion ≈ $225.69 Million |
CN¥28.45 Million ≈ $4.16 Million |
0.018x | -69.16% |
| 2012-12-31 | CN¥1.47 Billion ≈ $214.69 Million |
CN¥87.78 Million ≈ $12.84 Million |
0.060x | -37.90% |
| 2011-12-31 | CN¥1.45 Billion ≈ $212.23 Million |
CN¥139.72 Million ≈ $20.45 Million |
0.096x | -28.46% |
| 2010-12-31 | CN¥1.38 Billion ≈ $201.89 Million |
CN¥185.79 Million ≈ $27.19 Million |
0.135x | -23.16% |
| 2009-12-31 | CN¥1.26 Billion ≈ $184.46 Million |
CN¥220.92 Million ≈ $32.33 Million |
0.175x | +64.40% |
| 2008-12-31 | CN¥1.23 Billion ≈ $180.11 Million |
CN¥131.21 Million ≈ $19.20 Million |
0.107x | +54.21% |
| 2007-12-31 | CN¥1.18 Billion ≈ $172.41 Million |
CN¥81.45 Million ≈ $11.92 Million |
0.069x | -48.54% |
| 2006-12-31 | CN¥1.01 Billion ≈ $148.10 Million |
CN¥135.96 Million ≈ $19.90 Million |
0.134x | +153.75% |
| 2005-12-31 | CN¥1.10 Billion ≈ $160.52 Million |
CN¥58.08 Million ≈ $8.50 Million |
0.053x | -39.23% |
| 2004-12-31 | CN¥1.15 Billion ≈ $168.88 Million |
CN¥100.54 Million ≈ $14.71 Million |
0.087x | +17.72% |
| 2003-12-31 | CN¥1.11 Billion ≈ $161.93 Million |
CN¥81.89 Million ≈ $11.98 Million |
0.074x | -57.74% |
| 2002-12-31 | CN¥539.91 Million ≈ $79.01 Million |
CN¥94.55 Million ≈ $13.84 Million |
0.175x | +17.59% |
| 2001-12-31 | CN¥544.27 Million ≈ $79.64 Million |
CN¥81.05 Million ≈ $11.86 Million |
0.149x | +34.76% |
| 2000-12-31 | CN¥496.50 Million ≈ $72.65 Million |
CN¥54.87 Million ≈ $8.03 Million |
0.111x | -- |
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more